[{"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-001", "question": "A 45-year-old man presents with progressive bilateral leg weakness, urinary incontinence, and episodic vertigo over 6 months. Examination reveals spastic paraparesis, upbeat nystagmus, and a positive Romberg sign. MRI shows T2 hyperintensities in the cerebellar peduncles and periventricular white matter. CSF analysis is normal except for elevated IgG index. What is the most likely diagnosis?", "options": ["Primary progressive multiple sclerosis", "Susac syndrome", "Behçet disease", "Neuromyelitis optica spectrum disorder", "Cerebrotendinous xanthomatosis"], "answer": "B", "answer_index": 1, "explanation": "Susac syndrome is characterized by the triad of encephalopathy, branch retinal artery occlusions, and sensorineural hearing loss, but can present with cerebellar involvement and white matter lesions mimicking multiple sclerosis. Primary progressive multiple sclerosis typically lacks the specific upbeat nystagmus and vertigo seen here, while Behçet disease often includes oral ulcers and uveitis, which are absent. Neuromyelitis optica spectrum disorder usually features optic neuritis or transverse myelitis with aquaporin-4 antibodies, not present in this case.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N\\nVerdict on keyed answer: No defensible answer\\nKey stem clues: 45-year-old man with 6-month progressive spastic paraparesis, urinary incontinence (suggestive of myelopathy), episodic vertigo, upbeat nystagmus, positive Romberg; MRI with T2 hyperintensities in cerebellar peduncles and periventricular white matter; CSF with elevated IgG index.\\nThe vignette plus MRI and CSF profile most closely resemble a chronic demyelinating CNS disorder such as multiple sclerosis. The listed option “Primary progressive multiple sclerosis” is therefore the most plausible among the offered diagnoses. By contrast, Susac syndrome classically presents in young women with encephalopathy, branch retinal artery occlusions, and sensorineural hearing loss; brain MRI typically shows characteristic corpus callosum microinfarcts rather than isolated periventricular and cerebellar peduncle lesions, and there is no reason given here to suspect retinal or auditory involvement. The keyed explanation is internally inconsistent with the stem, incorrectly downplays MS (upbeat nystagmus and vertigo can occur with MS brainstem/cerebellar plaques) and provides no positive evidence for Susac.\\nMain medical issue: teaching point for Susac is inaccurate and not supported by the case. Minimal fix: change the key (and explanation) to primary progressive multiple sclerosis or adjust stem to include classic Susac triad and callosal lesions.\\n\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N\nVerdict on keyed answer: No defensible answer\nKey stem clues: 45-year-old man with 6-month progressive spastic paraparesis, urinary incontinence (suggestive of myelopathy), episodic vertigo, upbeat nystagmus, positive Romberg; MRI with T2 hyperintensities in cerebellar peduncles and periventricular white matter; CSF with elevated IgG index.\nThe vignette plus MRI and CSF profile most closely resemble a chronic demyelinating CNS disorder such as multiple sclerosis. The listed option “Primary progressive multiple sclerosis” is therefore the most plausible among the offered diagnoses. By contrast, Susac syndrome classically presents in young women with encephalopathy, branch retinal artery occlusions, and sensorineural hearing loss; brain MRI typically shows characteristic corpus callosum microinfarcts rather than isolated periventricular and cerebellar peduncle lesions, and there is no reason given here to suspect retinal or auditory involvement. The keyed explanation is internally inconsistent with the stem, incorrectly downplays MS (upbeat nystagmus and vertigo can occur with MS brainstem/cerebellar plaques) and provides no positive evidence for Susac.\nMain medical issue: teaching point for Susac is inaccurate and not supported by the case. Minimal fix: change the key (and explanation) to primary progressive multiple sclerosis or adjust stem to include classic Susac triad and callosal lesions.\n", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-002", "question": "A 32-year-old woman with a history of atopic dermatitis develops widespread pruritic vesicles and bullae after starting a new biologic therapy. Biopsy shows subepidermal clefting with eosinophils and flame figures. Direct immunofluorescence is negative. What is the most appropriate next step in management?", "options": ["Switch to dupilumab", "Initiate dapsone therapy", "Administer rituximab", "Prescribe high-dose systemic corticosteroids", "Perform patch testing for contact allergens"], "answer": "B", "answer_index": 1, "explanation": "This presentation suggests bullous pemphigoid-like eruption induced by biologic therapy, but the flame figures and eosinophilic spongiosis point to eosinophilic cellulitis (Wells syndrome), which responds well to dapsone. Switching to dupilumab might exacerbate atopic conditions without addressing the eosinophilic component, while rituximab is reserved for refractory autoimmune bullous diseases. Systemic corticosteroids could provide temporary relief but are not first-line for this entity.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U/M (underspecified leading to multiple defensible answers)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: Atopic dermatitis; new biologic; widespread pruritic vesicles/bullae; biopsy with subepidermal clefting, eosinophils, flame figures; direct IF negative. The explanation interprets this as Wells syndrome/eosinophilic cellulitis and endorses dapsone.\\nMain logical issues: The histologic description is mixed: subepidermal clefting with eosinophils is classic for bullous pemphigoid, while flame figures suggest Wells syndrome; negative DIF could occur in early or treated bullous pemphigoid or in technical issues. The question asks for the “most appropriate next step,” but no prior treatments (e.g., topical vs systemic steroids) or disease severity context are given. For Wells syndrome, both high‑dose systemic corticosteroids and dapsone are acceptable first‑line options; many references consider systemic steroids the main initial therapy. Thus B and D are both defensible, and picking dapsone as uniquely best requires unstated preference assumptions.\\nMain medical accuracy issues: The assertion that systemic corticosteroids are “not first-line” for Wells syndrome is at least debatable and likely inaccurate; they are commonly used first-line.\\nMinimal fix: Clarify in the stem that the patient has failed or cannot take systemic corticosteroids, or specify “steroid-sparing therapy,” to justify dapsone as uniquely best, and/or remove option D.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U/M (underspecified leading to multiple defensible answers)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: Atopic dermatitis; new biologic; widespread pruritic vesicles/bullae; biopsy with subepidermal clefting, eosinophils, flame figures; direct IF negative. The explanation interprets this as Wells syndrome/eosinophilic cellulitis and endorses dapsone.\nMain logical issues: The histologic description is mixed: subepidermal clefting with eosinophils is classic for bullous pemphigoid, while flame figures suggest Wells syndrome; negative DIF could occur in early or treated bullous pemphigoid or in technical issues. The question asks for the “most appropriate next step,” but no prior treatments (e.g., topical vs systemic steroids) or disease severity context are given. For Wells syndrome, both high‑dose systemic corticosteroids and dapsone are acceptable first‑line options; many references consider systemic steroids the main initial therapy. Thus B and D are both defensible, and picking dapsone as uniquely best requires unstated preference assumptions.\nMain medical accuracy issues: The assertion that systemic corticosteroids are “not first-line” for Wells syndrome is at least debatable and likely inaccurate; they are commonly used first-line.\nMinimal fix: Clarify in the stem that the patient has failed or cannot take systemic corticosteroids, or specify “steroid-sparing therapy,” to justify dapsone as uniquely best, and/or remove option D.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-003", "question": "A 58-year-old man with incomplete tetraplegia from a C5 spinal cord injury undergoes functional electrical stimulation therapy. After 3 months, he develops shoulder pain and limited abduction. Imaging reveals heterotopic ossification around the glenohumeral joint. What is the most effective intervention to preserve joint mobility?", "options": ["Bisphosphonate therapy", "Low-dose radiation", "Surgical excision", "Indomethacin prophylaxis", "Passive range-of-motion exercises"], "answer": "B", "answer_index": 1, "explanation": "Low-dose radiation therapy is highly effective in preventing maturation of heterotopic ossification in spinal cord injury patients, preserving joint function without systemic side effects. Bisphosphonates like etidronate can inhibit mineralization but are less targeted and may cause gastrointestinal issues. Surgical excision is considered only after ossification matures and if function is severely impaired, not as a primary intervention.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (Miskeyed)\\nVerdict on keyed answer: Miskeyed – choice C is the best answer, not B.\\nKey stem clues: Established heterotopic ossification (HO) already visible on imaging around the glenohumeral joint, with clinical pain and limited abduction after 3 months of FES in a chronic C5 SCI patient. The question asks for the most effective intervention to preserve joint mobility, not for primary prophylaxis.\\nLogical/medical issues: Low-dose radiation (B) is well supported as prophylaxis (perioperative or early post-injury) to prevent HO formation/maturation, especially around hip/major joints, but once clinically significant, function-limiting HO has formed, the standard most effective treatment to restore/preserve mobility is surgical excision (C) after maturation, often combined with prophylaxis (NSAID or radiation). Bisphosphonates and indomethacin are prophylactic/adjunctive, not primary treatment of established HO. Passive ROM is important but not the most effective specific HO intervention.\\nMain medical accuracy issue: The explanation incorrectly implies radiation is the primary/most effective management of already formed, symptomatic HO. That contradicts typical rehab/orthopedic standards.\\nMinimal fix: Change the keyed answer (and explanation) to C. Surgical excision, or alternatively revise the stem to clearly ask about prophylaxis in early post-injury period and remove mention of established ossification on imaging.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed)\nVerdict on keyed answer: Miskeyed – choice C is the best answer, not B.\nKey stem clues: Established heterotopic ossification (HO) already visible on imaging around the glenohumeral joint, with clinical pain and limited abduction after 3 months of FES in a chronic C5 SCI patient. The question asks for the most effective intervention to preserve joint mobility, not for primary prophylaxis.\nLogical/medical issues: Low-dose radiation (B) is well supported as prophylaxis (perioperative or early post-injury) to prevent HO formation/maturation, especially around hip/major joints, but once clinically significant, function-limiting HO has formed, the standard most effective treatment to restore/preserve mobility is surgical excision (C) after maturation, often combined with prophylaxis (NSAID or radiation). Bisphosphonates and indomethacin are prophylactic/adjunctive, not primary treatment of established HO. Passive ROM is important but not the most effective specific HO intervention.\nMain medical accuracy issue: The explanation incorrectly implies radiation is the primary/most effective management of already formed, symptomatic HO. That contradicts typical rehab/orthopedic standards.\nMinimal fix: Change the keyed answer (and explanation) to C. Surgical excision, or alternatively revise the stem to clearly ask about prophylaxis in early post-injury period and remove mention of established ossification on imaging.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-004", "question": "A 67-year-old woman with a history of migraine presents with acute onset of hemianopia, ataxia, and confusion. CT angiography shows occlusion of the posterior inferior cerebellar artery with extension into the basilar artery. Despite thrombolysis, she deteriorates with locked-in syndrome. What rare complication is most likely responsible for this progression?", "options": ["Reperfusion injury", "Basilar artery dissection", "Paradoxical embolism", "Top-of-the-basilar syndrome", "Intracranial atherosclerotic disease"], "answer": "C", "answer_index": 2, "explanation": "Paradoxical embolism through a patent foramen ovale can cause extension of infarction in vertebrobasilar territory, leading to locked-in syndrome despite initial thrombolysis. Reperfusion injury typically manifests as hemorrhage, not progression of ischemia, while basilar artery dissection would show characteristic imaging findings not described. Top-of-the-basilar syndrome involves thalamic and midbrain infarction but lacks the cerebellar involvement here.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N (no answer clearly defensible)\\nVerdict on keyed answer: Misleading; no option is clearly supported, and C is poorly justified.\\nKey stem clues: Acute vertebrobasilar stroke (PICA with basilar extension), initial hemianopia/ataxia/confusion, then deterioration to locked‑in syndrome after thrombolysis. Question asks for a “rare complication … responsible for this progression.” No PFO, DVT, or right‑to‑left shunt history is given, so paradoxical embolism is speculative. Thrombolysis failure or progression of basilar thrombosis is plausible but not listed. Reperfusion injury (A) generally causes hemorrhage and mass effect, not extension of ischemia, but this is not explicitly excluded by the stem. Basilar dissection (B) could cause progression but is not described. Top‑of‑the‑basilar (D) is a static anatomic syndrome, not a “complication.” Intracranial atherosclerotic disease (E) is chronic, not an acute “rare complication.”\\nMain logical issue: The stem does not provide any specific evidence for paradoxical embolism or any other listed option; the path given in the explanation (PFO) is entirely unstated, so no answer is defensible from the vignette.\\nMain medical accuracy issue: The explanation’s mechanism is plausible in general but not tied to this case.\\nMinimal fix: Add explicit PFO/right‑to‑left shunt and DVT findings, or change the options to include thrombus propagation/failed recanalization as the answer.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N (no answer clearly defensible)\nVerdict on keyed answer: Misleading; no option is clearly supported, and C is poorly justified.\nKey stem clues: Acute vertebrobasilar stroke (PICA with basilar extension), initial hemianopia/ataxia/confusion, then deterioration to locked‑in syndrome after thrombolysis. Question asks for a “rare complication … responsible for this progression.” No PFO, DVT, or right‑to‑left shunt history is given, so paradoxical embolism is speculative. Thrombolysis failure or progression of basilar thrombosis is plausible but not listed. Reperfusion injury (A) generally causes hemorrhage and mass effect, not extension of ischemia, but this is not explicitly excluded by the stem. Basilar dissection (B) could cause progression but is not described. Top‑of‑the‑basilar (D) is a static anatomic syndrome, not a “complication.” Intracranial atherosclerotic disease (E) is chronic, not an acute “rare complication.”\nMain logical issue: The stem does not provide any specific evidence for paradoxical embolism or any other listed option; the path given in the explanation (PFO) is entirely unstated, so no answer is defensible from the vignette.\nMain medical accuracy issue: The explanation’s mechanism is plausible in general but not tied to this case.\nMinimal fix: Add explicit PFO/right‑to‑left shunt and DVT findings, or change the options to include thrombus propagation/failed recanalization as the answer.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-005", "question": "A 28-year-old man presents with erythematous plaques on the trunk and extremities that worsen with sun exposure. Biopsy reveals interface dermatitis with vacuolar degeneration and apoptotic keratinocytes. Serology shows positive anti-Ro/SSA antibodies. Despite hydroxychloroquine, lesions persist. What is the most appropriate adjunctive therapy?", "options": ["Thalidomide", "Mycophenolate mofetil", "Intravenous immunoglobulin", "Lenalidomide", "Apremilast"], "answer": "A", "answer_index": 0, "explanation": "This is subacute cutaneous lupus erythematosus, and thalidomide is effective for refractory cases with photosensitivity and anti-Ro positivity due to its anti-angiogenic and immunomodulatory effects. Mycophenolate mofetil is more suited for systemic lupus but less effective for cutaneous-limited disease. Intravenous immunoglobulin is reserved for severe systemic involvement, not primarily cutaneous manifestations.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 28-year-old man; photodistributed erythematous plaques on trunk/extremities; histology showing interface dermatitis with vacuolar change and apoptotic keratinocytes; positive anti-Ro/SSA antibodies; persistent lesions despite hydroxychloroquine. This presentation is classic for subacute cutaneous lupus erythematosus (SCLE) refractory to first-line antimalarial therapy.\\n\\nAmong options, thalidomide has well-documented efficacy for severe, refractory cutaneous lupus (including SCLE) due to immunomodulatory and TNF-α–inhibitory effects; it is a recognized second/third-line agent despite neurotoxicity and teratogenicity. Mycophenolate is more often used for systemic organ involvement; its role in isolated refractory cutaneous disease is less established than thalidomide. IVIG is reserved for severe systemic/hematologic/neuro involvement, not primarily cutaneous lesions. Lenalidomide and apremilast have some emerging/limited evidence but are not standard of care or clearly superior choices in a board-style single-best-answer framework.\\n\\nMain medical accuracy issues: Minor—thalidomide’s main mechanism is immunomodulatory/TNF inhibition rather than “anti-angiogenic” as the key efficacy explanation for SCLE. Overall teaching point and management hierarchy are consistent with current standards.\\n\\nMinimal fix: Clarify in stem that this is “refractory SCLE despite optimized antimalarial therapy and photoprotection” to highlight indication for thalidomide and justify it over other immunosuppressants.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 28-year-old man; photodistributed erythematous plaques on trunk/extremities; histology showing interface dermatitis with vacuolar change and apoptotic keratinocytes; positive anti-Ro/SSA antibodies; persistent lesions despite hydroxychloroquine. This presentation is classic for subacute cutaneous lupus erythematosus (SCLE) refractory to first-line antimalarial therapy.\n\nAmong options, thalidomide has well-documented efficacy for severe, refractory cutaneous lupus (including SCLE) due to immunomodulatory and TNF-α–inhibitory effects; it is a recognized second/third-line agent despite neurotoxicity and teratogenicity. Mycophenolate is more often used for systemic organ involvement; its role in isolated refractory cutaneous disease is less established than thalidomide. IVIG is reserved for severe systemic/hematologic/neuro involvement, not primarily cutaneous lesions. Lenalidomide and apremilast have some emerging/limited evidence but are not standard of care or clearly superior choices in a board-style single-best-answer framework.\n\nMain medical accuracy issues: Minor—thalidomide’s main mechanism is immunomodulatory/TNF inhibition rather than “anti-angiogenic” as the key efficacy explanation for SCLE. Overall teaching point and management hierarchy are consistent with current standards.\n\nMinimal fix: Clarify in stem that this is “refractory SCLE despite optimized antimalarial therapy and photoprotection” to highlight indication for thalidomide and justify it over other immunosuppressants.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-006", "question": "A 42-year-old woman with rheumatoid arthritis and secondary fibromyalgia undergoes multidisciplinary pain management. She reports persistent widespread pain despite optimized pharmacotherapy. Quantitative sensory testing shows central sensitization. What advanced rehabilitation technique is most likely to provide long-term benefit?", "options": ["Graded motor imagery", "Transcutaneous electrical nerve stimulation", "Aquatic therapy", "Cognitive behavioral therapy alone", "Spinal cord stimulation"], "answer": "A", "answer_index": 0, "explanation": "Graded motor imagery effectively addresses central sensitization in fibromyalgia by reprogramming cortical representations, leading to sustained pain reduction in rheumatoid arthritis overlap. Transcutaneous electrical nerve stimulation provides short-term relief but does not target central mechanisms. Spinal cord stimulation is invasive and indicated for neuropathic pain, not widespread fibromyalgia pain.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: 42-year-old woman with RA and secondary fibromyalgia; persistent widespread pain despite optimized pharmacotherapy; quantitative sensory testing shows central sensitization; asks for “advanced rehabilitation technique…most likely to provide long-term benefit.”\\n\\nThe central construct is chronic widespread pain with documented central sensitization in a fibromyalgia context. Among options, both graded motor imagery (GMI) and cognitive behavioral therapy (CBT) have evidence and guideline support for addressing central sensitization and providing long-term benefit in fibromyalgia and chronic widespread pain. The stem gives no information privileging sensorimotor/cortical reprogramming over psychological/behavioral strategies. Describing CBT as “alone” does not make it inappropriate; CBT monotherapy is guideline-supported for fibromyalgia and central sensitization syndromes. Thus both A and D are reasonably defensible as “most likely to provide long-term benefit,” creating ambiguity.\\n\\nOther options: TENS (B) is typically short-term and peripheral; aquatic therapy (C) is beneficial but less specifically central-sensitization–targeted; spinal cord stimulation (E) is invasive and not standard for fibromyalgia.\\n\\nMain medical-accuracy issue: overstating GMI as the preferred/most evidence-based advanced rehabilitation for central sensitization in fibromyalgia versus CBT. \\n\\nMinimal fix: Rephrase the question to ask for “a sensorimotor cortical retraining technique” or remove CBT from the choices (replace D) to make GMI uniquely best.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: 42-year-old woman with RA and secondary fibromyalgia; persistent widespread pain despite optimized pharmacotherapy; quantitative sensory testing shows central sensitization; asks for “advanced rehabilitation technique…most likely to provide long-term benefit.”\n\nThe central construct is chronic widespread pain with documented central sensitization in a fibromyalgia context. Among options, both graded motor imagery (GMI) and cognitive behavioral therapy (CBT) have evidence and guideline support for addressing central sensitization and providing long-term benefit in fibromyalgia and chronic widespread pain. The stem gives no information privileging sensorimotor/cortical reprogramming over psychological/behavioral strategies. Describing CBT as “alone” does not make it inappropriate; CBT monotherapy is guideline-supported for fibromyalgia and central sensitization syndromes. Thus both A and D are reasonably defensible as “most likely to provide long-term benefit,” creating ambiguity.\n\nOther options: TENS (B) is typically short-term and peripheral; aquatic therapy (C) is beneficial but less specifically central-sensitization–targeted; spinal cord stimulation (E) is invasive and not standard for fibromyalgia.\n\nMain medical-accuracy issue: overstating GMI as the preferred/most evidence-based advanced rehabilitation for central sensitization in fibromyalgia versus CBT. \n\nMinimal fix: Rephrase the question to ask for “a sensorimotor cortical retraining technique” or remove CBT from the choices (replace D) to make GMI uniquely best.\n", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}]